Since our inception, our vision has been:
-The development of precision gene editing technologies for agriculture that does not use transgenes or recombinant DNA with which to develop trait products that were indistinguishable from traditional breeding (or nature); and
-A more efficient and targeted breeding industry regarding specific characteristics like disease resistance based on (non-GMO) precision gene editing technologies that is globally regulated on the same basis as conventional breeding.
In the era of global GMO restrictions, GMO markets were limited and, when available, GMO traits were both expensive and time consuming to breed and commercialize. We founded Cibus with the firm belief that the development of precision gene editing technologies was achievable and, once achieved, it would enable our second goal: a new era for agricultural trait development with global agricultural trade standards for both in-country cultivation and import/export regulations. The promise of global standards is a new era of global crop breeding innovations that would mirror the global genomic revolution in human healthcare.
Our mission is to harness the power of precision gene editing in agriculture and, in so doing, make farming more environmentally friendly, sustainable and profitable.
We have built an industry-leading new breeding platform, based on gene editing technologies. Our platform is called RTDS™, Rapid Trait Development System™. RTDS is a family of technologies that are protected by over 300 patents and patent applications that cover multiple layers of intellectual property. It represents a system of technologies that integrates crop specific biological platforms with a series of gene editing technologies enabling trait development and their introgression into elite germplasm from our breeding partners with our automated Trait Machine™.
-The development of precision gene editing technologies for agriculture that does not use transgenes or recombinant DNA with which to develop trait products that were indistinguishable from traditional breeding (or nature); and
-A more efficient and targeted breeding industry regarding specific characteristics like disease resistance based on (non-GMO) precision gene editing technologies that is globally regulated on the same basis as conventional breeding.
In the era of global GMO restrictions, GMO markets were limited and, when available, GMO traits were both expensive and time consuming to breed and commercialize. We founded Cibus with the firm belief that the development of precision gene editing technologies was achievable and, once achieved, it would enable our second goal: a new era for agricultural trait development with global agricultural trade standards for both in-country cultivation and import/export regulations. The promise of global standards is a new era of global crop breeding innovations that would mirror the global genomic revolution in human healthcare.
Our mission is to harness the power of precision gene editing in agriculture and, in so doing, make farming more environmentally friendly, sustainable and profitable.
We have built an industry-leading new breeding platform, based on gene editing technologies. Our platform is called RTDS™, Rapid Trait Development System™. RTDS is a family of technologies that are protected by over 300 patents and patent applications that cover multiple layers of intellectual property. It represents a system of technologies that integrates crop specific biological platforms with a series of gene editing technologies enabling trait development and their introgression into elite germplasm from our breeding partners with our automated Trait Machine™.
Location: United States, California, Sorrento Valley
Employees: 51-200
Total raised: $70M
Founded date: 2001
Investors 1
| Date | Name | Website |
| - | Scientia V... | scientiavc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.06.2018 | Series C | $70M | - |
Mentions in press and media 17
| Date | Title | Description |
| 12.11.2024 | ROTH to Host 13th Annual Technology Conference at the Hard Rock Hotel in New York City | Event to feature one-on-one meetings between institutional investors and senior management from over 110 companies across a variety of technology sub-sectors NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN -- Roth Capital Partners, LLC ... |
| 13.03.2024 | Cibus to Participate in the 36th Annual Roth Conference | - |
| 07.03.2024 | Cibus closes PE and venture funds at combined $645m | - |
| 07.03.2024 | Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call | - |
| 18.01.2023 | Brief: Gene editing companies Calyxt and Cibus plan merger to become Cibus Inc amid signs of struggles | Two crop gene editing companies Calyxt and Cibus plan to merge to focus on trait development and plant breeding., with the new entity taking on Cibus’ name. Financial terms of the all-stock transaction are undisclosed. It appears Calyxt’s v... |
| 28.06.2018 | Cibus Secures $70M Series C Funding | SAN DIEGO, CA, Cibus, a leader in the application of gene editing technologies for directed mutagenesis, announced it has raised $70 million in a Series C funding. >> Click here for more funding data on Cibus >> To export Ci... |
| 26.06.2018 | Cibus Raises $70m Series C for Gene Editing “Indistinguishable” from Traditional Plant Breeding | **Stay tuned for further updates on the differences between Cibus’ RTDS process and other gene editing tools such as CRISPR Cas-9** Cibus, a company using gene editing technology to breed crops with improved characteristics, has raised $70 ... |
| 26.06.2018 | Cibus Raises $70M in Series C Funding | Cibus, a San Diego, CA-based leader in the application of gene editing technologies for directed mutagenesis, raised $70m in Series C funding. The round was led by Fidelity Management and Research Company and joined by Alexandria Venture In... |
| 30.03.2018 | Crispr’d Food, Coming Soon to a Supermarket Near You | For years now, the US Department of Agriculture has been flirting with the latest and greatest DNA manipulation technologies. Since 2016, it has given free passes to at least a dozen gene-edited crops, ruling that they fall outside its regu... |
| 31.07.2017 | Cibus Raises Over $57 Million | Local agtech company Cibus has raised over $57 million in an equity round, according to paperwork the company filed with the U.S. Securities and Exchange Commission. The capital comes from 62 investors, with the first sale of stock dating b... |
Show more